Literature DB >> 29125222

Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs.

Yi-Xing Chen1, Chao Liu1, Nan Liu2, Ye Wu3, Qing-Jie Zhao1, Hong-Gang Hu1, Xiang Li1, Yan Zou1.   

Abstract

As natural-product-derived antibiotics, desotamides A - D and wollamides exhibit growth inhibitory activity against Gram-posivite bacteria (IC50 0.6 - 7 μm) and are noncytotoxic to mammalian cells (IC50  > 30 μm). Herein we firstly report the total synthesis of above two cyclohexapeptides as well as a series of structural variants through solid phase peptide synthesis, of which 3 displayed a 2-fold increase of antibacterial activity when compared with the original peptide 1. This strategy may offer good improvements for the synthesis of other cyclic peptides.
© 2018 Wiley-VHCA AG, Zurich, Switzerland.

Entities:  

Keywords:  zzm321990SPPSzzm321990; Antibacterial activity; Desotamides; Total synthesis; Wollamides

Mesh:

Substances:

Year:  2017        PMID: 29125222     DOI: 10.1002/cbdv.201700414

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  3 in total

Review 1.  Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.

Authors:  Ricardo Ribeiro; Eugénia Pinto; Carla Fernandes; Emília Sousa
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

Review 2.  Recent Reports of Solid-Phase Cyclohexapeptide Synthesis and Applications.

Authors:  Allan M Prior; Taylor Hori; Ashriel Fishman; Dianqing Sun
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

3.  Analysis of Biosynthetic Gene Clusters, Secretory, and Antimicrobial Peptides Reveals Environmental Suitability of Exiguobacterium profundum PHM11.

Authors:  Alok Kumar Srivastava; Ruchi Srivastava; Akhilendra Pratap Bharati; Alok Kumar Singh; Anjney Sharma; Sudipta Das; Praveen Kumar Tiwari; Anchal Kumar Srivastava; Hillol Chakdar; Prem Lal Kashyap; Anil Kumar Saxena
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.